NF1 deletion patients significantly more often presented with symptomatic spinal neurofibromas, cardiovascular and skeletal abnormalities, learning disabilities, dysmorphism, and malignancies when compared to a “classic NF1” cohort, in a cohort of 126 NF1 deletions patients [1]. This evidence concerns the gene NF1 and Spinal neurofibroma.